Eli Lilly and Co
Morgan Stanley names Eli Lilly a top pick, says it has best product outlook in pharma
An exciting new drug for diabetes and weight loss could open up a whole new market for the company, analysts say. Source
Read More
Investing Club: Here’s our April rapid-fire update on all 33 stocks in Cramer’s Charitable Trust portfolio
Ahead of our Monthly Meeting this Thursday, we are providing the Club with a quick refresher on all the holdings in the portfolio. Source
Read More
Investors bet on obesity drugs before without much success. Why this next wave could be different
New obesity treatments are helping patients lose 15% or more of their body weight, and changing attitudes could expand access to treatments. Source
Read More
Jim Cramer says investors should use these rules to build a turbulence-proof portfolio
Investors should follow a certain set of rules when building their portfolios to weather the market volatility that Monday’s rally suggests could happen, Jim Cramer said. “When you see new, unseasoned merchandise exploding higher, along with names like Tesla surging on … a stock split, it tells you there might be a little too much […]
Read More
Two years into the coronavirus pandemic, Fauci hopes the world will not forget lessons from a ‘catastrophic experience’
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, arrives for a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters As the two-year anniversary of the coronavirus […]
Read More